Atlas Trials

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2017 Injection in Postmenopausal Women

Clinical trial NCT05930704 · UNKNOWN

Trial details

NCT number
NCT05930704
Sponsor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Osteoporosis
Start date
2023-07-04
Primary completion
2025-04-12
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.